Reportee | Signature Date | Report period | Total Entries | Total AUM($) |
---|---|---|---|---|
BANK OF AMERICA CORP /DE/ | 05-15-2024 | 03-31-2024 | 25473 | 1,067,158,623,318 |
Issuer | Class | Position | Value | Shares | Portfolio Percentage (%) | Previous Percentage (%) | Shares Delta | Shares Delta(%) | Date Reported |
---|---|---|---|---|---|---|---|---|---|
NURIX THERAPEUTICS INC | COM | 6551 | $1,428,488 | 97,176 | 0.00 | 0.00 | 78,240 | 413.18 | 03-31-2024 |
POINT BIOPHARMA GLOBAL INC | COM | Liquidated | $0 | 0 | 0.00 | 0.00 | -231,646 | -59.51 | 12-31-2023 |
LAKELAND BANCORP INC | COM | 6553 | $1,425,137 | 117,780 | 0.00 | 0.00 | 142 | 0.12 | 03-31-2024 |
INVESCO EXCH TRADED FD TR II | S&P 500 EX RAT | 6554 | $1,423,171 | 28,456 | 0.00 | 0.00 | -205 | -0.72 | 03-31-2024 |